LOUISVILLE, Ky.--(BUSINESS WIRE)--The Humana Foundation, the philanthropic arm of Humana Inc. (NYSE: HUM) for the past 44 years, today announced $500,000 in new investments to support food banks and nutrition programs in four states. The funding will help address urgent needs in communities where the loss of food assistance for nearly 42 million Americans, have intensified food insecurity. Thes...
LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that Celeste Mellet, Chief Financial Officer, will make a presentation to investors at the Wolfe Research Healthcare Conference on Wednesday, November 19, 2025, at 8:40 a.m. Eastern time. A live audio webcast of the presentation will be available via Humana's Investor Relations page at https://humana.gcs-web.com/. The com...
Humana Inc. ( HUM ) Q3 2025 Earnings Call November 5, 2025 8:00 AM EST Company Participants Lisa Stoner - Vice President of Investor Relations James Rechtin - President, CEO & Director Celeste Mellet - Chief Financial Officer David Dintenfass - President of Enterprise Growth George Renaudin - President of Insurance Conference Call Participants Andrew Mok - Barclays Bank PLC, Research Division A...
Humana receives a "Hold" rating due to fair valuation and ongoing underperformance versus the S&P 500. HUM's Q3 earnings beat expectations, but a light FY 2025 outlook and higher medical loss ratio pressured shares. Management aims to double Medicare Advantage margins by 2026, but faces headwinds from declining membership and regulatory changes.
Humana Wednesday reported $195 million in third quarter profits as the health insurer's medical cost trends were in line with the company's earlier forecasts.
Humana reported lower third-quarter profit and slashed full-year earnings guidance as medical costs continue to surge, dragging down margins for the company's core Medicare Advantage business.
Humana reported third-quarter profit that beat Wall Street estimates on Wednesday, on higher premiums.
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.